Ductal carcinoma in situ: Correlation between FDG-PET/CT and histopathology

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 26, Issue 8, 2008, Pages 488-493

  Azuma, Asako ^a   Tozaki, Mitsuhiro ^a   Ito, Kensuke ^a   Fukuma, Eisuke ^a   Tanaka, Tomoko ^a   O'Uchi, Toshihiro ^a  

^a KAMEDA MEDICAL CENTER   (Japan)

Author keywords

Breast cancer; DCIS; FDG PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CARCINOMA IN SITU; CELL DENSITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55949096775     PISSN: 02882043     EISSN: 18625274     Source Type: Journal    
DOI: 10.1007/s11604-008-0263-6     Document Type: Article

References (12)

1. A.Y. Rostom J. Powe A. Kandil A. Ezzat S. Bakheet F. el-Khwsky 1999 Positron emission tomography in breast cancer: a clinicopathological correlation of results Br J Radiol 72 1064 1068
2. N. Avril C.A. Rose M. Schelling J. Dose W. Kuhn S. Bense 2000 Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations J Clin Oncol 18 3495 3502
3. 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes J Nucl Med 47 1440 1446
4. L.J. Esserman A.S. Kumar A.F. Herrera J. Leung A. Au Y.Y. Chen 2006 Magnetic resonance imaging captures the biology of ductal carcinoma in situ J Clin Oncol 24 4603 4610
5. I. De Mascarel F. Bonichon G. MacGrogan C.T. de Lara A. Avril V. Picot 2000 Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations Breast Cancer Res Treat 61 151 159
6. T. Owaki Y. Kijima H. Yoshinaka Y. Uenosono T. Yoshioka S. Natsugoe 2006 Ductal carcinoma in-situ of the breast detected by [F-18] fluorodeoxyglucose positron emission tomography Breast Cancer 13 210 213
7. N. Avril J. Dose F. Jänicke S. Bense S. Ziegler C. Laubenbacher 1996 Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose J Clin Oncol 14 1848 1857
8. R. Kumar A. Chauhan H. Zhuang P. Chandra M. Schnall A. Alavi 2006 Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro- D:-glucose positron emission tomography: variations with age, breast density, and menopausal status Mol Imaging Biol 8 355 362
9. F. Dehdashti J.E. Mortimer B.A. Siegel L.K. Griffeth T.J. Bonasera M.J. Fusselman 1995 Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDGPET and in vitro receptor assays J Nucl Med 36 1766 1774
10. A. Buck H. Schirrmeister T. Kühn T. Shen T. Kalker J. Kotzerke 2002 FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters Eur J Nucl Med Mol Imaging 29 1317 1323
11. 18FFDG PET: histologic and immunohistochemical tissue analysis J Nucl Med 42 9 16
12. S. Nakamura H. Kenjo T. Nishio T. Kazama O. Do K. Suzuki 2001 3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET Breast Cancer 8 351 354